Description
Clinical Description
RRS® Silisorg is a professional mesotherapy and biorevitalisation solution developed by Skin Tech Pharma Group for the management of skin ageing, loss of firmness, and connective tissue deterioration. The product combines organic silicon with a carefully selected blend of amino acids, vitamins, antioxidants, trace elements, and coenzymes intended to support dermal metabolism and extracellular matrix function.
Unlike hyaluronic acid-based skin boosters that primarily focus on hydration, RRS® Silisorg is formulated to target connective tissue support and skin revitalisation through a multi-ingredient approach. Organic silicon is widely recognised for its role in collagen and elastin metabolism, while the complementary ingredients are designed to contribute to overall skin quality maintenance.
The product is supplied in sterile 5ml vials and is intended exclusively for professional administration within aesthetic medical settings. RRS® Silisorg is commonly incorporated into facial and body rejuvenation protocols addressing visible signs of ageing, skin laxity, and reduced tissue quality.
What RRS® Silisorg Is Similar To
RRS® Silisorg belongs to the category of mesotherapy and biorevitalisation solutions. It shares certain characteristics with products such as NCTF® 135 HA and Jalupro®, although important differences exist.
Like NCTF® 135 HA, RRS® Silisorg contains a broad spectrum of revitalising ingredients including vitamins, amino acids, minerals, and antioxidants designed to support skin quality. However, NCTF® includes hyaluronic acid as a central component, whereas RRS® Silisorg focuses primarily on organic silicon-based revitalisation.
Compared with Jalupro®, both products utilise amino acid complexes to support dermal metabolism. However, Jalupro® is specifically centred around amino acid and hyaluronic acid combinations, while RRS® Silisorg incorporates organic silicon together with a broader nutritional complex.
RRS® Silisorg is generally positioned as a connective tissue-supporting mesotherapy solution rather than a volumising filler or hydration-focused skin booster.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer and distributor documentation, RRS® Silisorg may be used in protocols involving:
- Face
- Neck
- Décolletage
- Hands
- Body areas demonstrating reduced skin quality
- Areas affected by skin ageing and loss of firmness
Primary indications include:
- Skin ageing
- Reduced skin elasticity
- Connective tissue deterioration
- Skin laxity
- Dermal revitalisation
- General skin quality improvement
Usage / Administration (IFU-Only Section)
Professional-use statement: RRS® Silisorg is intended exclusively for administration by qualified medical professionals using appropriate aseptic techniques and clinical protocols.[1]
⚠️ Important: Some practitioners utilise mesotherapy injection techniques for RRS® Silisorg; however, specific administration protocols were not identified within publicly accessible manufacturer IFU documentation and therefore are not included here.
Ingredient List
Active Components
- Organic Silicon (Silanol)
- Amino Acids
- Vitamins
- Minerals and Trace Elements
- Antioxidants
- Coenzymes
Excipients
- Physiological buffering solution
- Sterile aqueous carrier solution
Further quantitative composition details are not publicly disclosed within accessible product documentation.
Presentation & Longevity
Packaging
- 12 × 5ml sterile vials
- Total volume: 60ml
Product Classification
- Mesotherapy solution
- Biorevitalisation product
- Professional-use aesthetic medical device/product
Longevity
The duration of aesthetic outcomes may vary depending on patient characteristics, treatment protocols, lifestyle factors, and practitioner assessment.
Safety Notes / Contraindications
The manufacturer’s Instructions for Use should always be reviewed before treatment.
Important precautions include:
- Use only by appropriately trained healthcare professionals.
- Do not administer in areas of active infection or inflammation.
- Avoid use in patients with known hypersensitivity to any component.
- Treatment should be postponed when local skin disease or infection is present.
Where detailed IFU contraindications are unavailable, standard mesotherapy safety principles should be followed.
Use is contraindicated in patients with known hypersensitivity to any component or with active skin infections at the injection site.
Regulatory Status
- CE-marked professional aesthetic product according to manufacturer and distributor documentation.
- Intended for professional medical use only.
- Regulatory classification should be verified using the current manufacturer IFU and product packaging.
No FDA approval information was identified in publicly available documentation reviewed for this product.
FAQ
1. What is RRS® Silisorg?
RRS® Silisorg is a professional mesotherapy and biorevitalisation solution containing organic silicon together with amino acids, vitamins, antioxidants, minerals, and coenzymes. It is intended to support skin revitalisation and connective tissue quality in ageing or environmentally stressed skin.
2. How does RRS® Silisorg differ from hyaluronic acid skin boosters?
Unlike traditional hyaluronic acid skin boosters that primarily focus on hydration, RRS® Silisorg centres on organic silicon and a broad nutritional complex. The formulation is designed to support connective tissue metabolism and overall skin quality rather than delivering significant hydration through hyaluronic acid alone.
3. Is RRS® Silisorg a dermal filler?
No. RRS® Silisorg is not classified as a volumising dermal filler. It is a mesotherapy and biorevitalisation product intended to support skin quality and connective tissue function. Its purpose differs from fillers that are specifically designed to restore facial volume or contour.
4. Which treatment areas are commonly associated with RRS® Silisorg?
Manufacturer and distributor information indicates that RRS® Silisorg may be incorporated into protocols for the face, neck, décolletage, hands, and selected body areas displaying visible signs of ageing or reduced tissue quality. Treatment decisions remain the responsibility of the healthcare professional.
5. How long do results from RRS® Silisorg last?
The manufacturer does not publish a specific longevity claim in publicly available documentation. Treatment outcomes and duration may vary depending on individual patient factors, treatment protocols, and practitioner recommendations. Longevity should therefore be evaluated on a case-by-case basis.
